Association between tuberculosis, diabetes and 25 hydroxyvitamin D in Tanzania: A longitudinal case control study

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Boillat Blanco, Noémie ^a,b,c,d   Bovet, Pascal ^d   Ramaiya, Kaushik L ^e   Mganga, Maliwasa ^f   Minja, Lilian T ^a   Saleh, Lanja ^g   Imboden, Medea ^b,c   Schindler, Christian ^b,c   Gagneux, Sebastien ^b,c   Daubenberger, Claudia ^b,c   Reither, Klaus ^a,b,c   Probst Hensch, Nicole ^b,c  

^a IFAKARA HEALTH INSTITUTE   (Tanzania)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^f National Programme on Tuberculosis and Leprosy   (Tanzania)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Diabetes; Stress induced hyperglycemia; Transient hyperglycemia; Tuberculosis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; GLUCOSE; TUBERCULOSTATIC AGENT; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERGLYCEMIA; INFECTION RISK; LIFESTYLE MODIFICATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; SEX DIFFERENCE; SOCIAL STATUS; SPUTUM CYTODIAGNOSIS; TANZANIA; THORAX RADIOGRAPHY; TUBERCULOSIS; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICAL MODEL; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; TANZANIA; TUBERCULOSIS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 85009285170     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1960-x     Document Type: Article

References (37)

1. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5(7):e152.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.
3. Martineau AR. Old wine in new bottles: vitamin D in the treatment and prevention of tuberculosis. Proc Nutr Soc. 2012;71(1):84-9.
4. Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261-70.
5. Xuan Y, Zhao HY, Liu JM. Vitamin D and type 2 diabetes mellitus (D2). J Diabetes. 2013;5(3):261-7.
6. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011;364(3):248-54.
7. Powe CE, Evans MK, Wenger J, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013;369(21):1991-2000.
8. Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36(5):1422-8.
9. Hawn TR, Shah JA, Kalman D. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics. Immunol Rev. 2015;264(1):344-62.
10. Handel AE, Ramagopalan SV. Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis. 2010;10(9):596.
11. Chaudhary S, Thukral A, Tiwari S, Pratyush DD, Singh SK. Vitamin D status of patients with type 2 diabetes and sputum positive pulmonary tuberculosis. Indian J Endocrinol Metab. 2013;17 Suppl 3:S670-3.
12. Zhan Y, Jiang L. Status of vitamin D, antimicrobial peptide cathelicidin and T helper-associated cytokines in patients with diabetes mellitus and pulmonary tuberculosis. Exp Ther Med. 2015;9(1):11-6.
13. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci U S A. 2012;109(38):15449-54.
14. Kota SK, Jammula S, Tripathy PR, Panda S, Modi KD. Effect of vitamin D supplementation in type 2 diabetes patients with pulmonary tuberculosis. Diabetes Metab Syndr. 2011;5(2):85-9.
15. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet. 2011;377(9761):242-50.
16. Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38(1):3-5.
17. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. 2009;179(9):843-50.
18. Daley P, Jagannathan V, John KR, et al. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(5):528-34.
19. Boillat-Blanco N, Ramaiya KL, Mganga M, et al. Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis. 2016;213(7):1163-72.
20. URTanzania. United Republic of Tanzania. National Tuberculosis and Leprosy Programme and Ministry of Health and Social Welfare. Manual for the Management of Tuberculosis and Leprosy. 2013; 6th Ed.
21. NTLP. National Tuberculosis and Leprosy Programme and Ministry of Health and Social Welfare. The United Republic of Tanzania Ministry of Health and Social Welfare National Tuberculosis and Leprosy Programme annual report. http://ntlpgotz/indexphp?option=com_phocadownload&view=category&id=10:annualreports&Itemid=139. 2013. Accessed 25 Oct 2016.
22. WHO. Treatment of tuberculosis guidelines. 4th ed. Geneva: World Health Organization; 2010.
23. Hartung CA, Brunette W, Lerer A, Tseng C, Borriello G. Open Data Kit: building information services for developing regions. London: International Conference on Information and Communication Technologies for Development (ICTD); 2010.
24. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30.
25. Essack Y, Hoffman M, Rensburg M, Van Wyk J, Meyer CS, Erasmus R. A comparison of five glucometers in South Africa. JEMDSA. 2009;14(2):102-5.
26. WHO. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. 2006.
27. Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211-23.
28. Coussens AK, Wilkinson RJ, Nikolayevskyy V, et al. Ethnic variation in inflammatory profile in tuberculosis. PLoS Pathog. 2013;9(7):e1003468.
29. Friis H, Range N, Changalucha J, et al. Vitamin D status among pulmonary TB patients and non-TB controls: a cross-sectional study from Mwanza, Tanzania. PLoS One. 2013;8(12):e81142.
30. Koo HK, Lee JS, Jeong YJ, et al. Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. 2012;17(5):808-13.
31. Sloan DJ, Mwandumba HC, Kamdolozi M, et al. Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes. Int J Tuberc Lung Dis. 2015;19(8):904-11.
32. Sudfeld CR, Giovannucci EL, Isanaka S, et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections, and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis. 2013;207(3):378-85.
33. Martineau AR, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A. 2011;108(47):19013-7.
34. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113-9.
35. Durazo-Arvizu RA, Camacho P, Bovet P, et al. 25-Hydroxyvitamin D in African-origin populations at varying latitudes challenges the construct of a physiologic norm. Am J Clin Nutr. 2014;100(3):908-14.
36. Pareek M, Innes J, Sridhar S, et al. Vitamin D deficiency and TB disease phenotype. Thorax. 2015;70(12):1171-80.
37. Davies PD, Martineau AR. Vitamin D and tuberculosis: more effective in prevention than treatment? Int J Tuberc Lung Dis. 2015;19(8):876-7.